Literature DB >> 22588952

The study of soluble intercellular adhesion molecule-1 and ghrelin in adolescents with family history of type 2 diabetes.

Bo-Wei Liu1, Qiang Lu, Chun-Ming Ma, Jun-Ru Liu, Dong-Hui Lou, Xiao-Li Liu, Fu-Zai Yin.   

Abstract

The purpose of this study was to observe both the changes of soluble intercellular adhesion molecule-1 (sICAM-1) and ghrelin in adolescents with family history of type 2 diabetes (FHD) and the relationship between sICAM-1 and ghrelin. This case-control study included 63 adolescents (boys/girls 29/34, age 14.1 ± 0.7 years) without FHD (FHD-) and 67 adolescents (boys/girls 33/34, age 14.0 ± 0.8 years) with FHD (FHD+). Anthropometric measurements, including height, weight, waist circumference (WC), and blood pressure, were obtained. Blood samples were collected, and fasting plasma glucose (FPG), serum lipids, true insulin, sICAM-1, and ghrelin were assayed. The results showed that the age and gender were similar in two groups (P > 0.05). Body mass index (BMI), WC, FPG, fasting insulin, HOMA-IR, and sICAM-1 were all significantly higher in the FHD+ group than in the FHD- group (P < 0.05). Ghrelin was significantly lower in the FHD+ group than in the FHD- group (P < 0.05). sICAM-1 was positively correlated with WC (r = 0.178, P = 0.043), fasting insulin (r = 0.195, P = 0.026), HOMA-IR (r = 0.197, P = 0.024), and ghrelin (r = 0.290, P = 0.001). After multivariate analysis, the ghrelin (β = 0.788, 95 % CI: 0.416-1.159, P = 0.000) and HOMA-IR (β = 0.106, 95 % CI: 0.045-0.167, P = 0.001) maintained an independent association with sICAM-1. These findings led to the conclusion that endothelial dysfunction and decline of ghrelin were found in adolescents with family history of diabetes. The decline of ghrelin maybe a protection mechanism for endothelial function in adolescents with family history of diabetes and should be examined in future studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588952     DOI: 10.1007/s12020-012-9680-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

1.  Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes.

Authors:  T Østergård; T K Hansen; B Nyholm; C H Gravholt; C B Djurhuus; H Hosoda; K Kangawa; O Schmitz
Journal:  Diabetologia       Date:  2003-01       Impact factor: 10.122

2.  Effect of ghrelin on angiotensin II induced human umbilicus vein endothelial cell oxidative stress and endothelial cell injury.

Authors:  Bin Deng; Li Fang; Xiaobin Chen; Meifang Chen; Xiumei Xie
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2010-10

3.  Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents.

Authors:  M P Bahíllo-Curieses; F Hermoso-López; M J Martínez-Sopena; P Cobreros-García; P García-Saseta; M Tríguez-García; J M Marugán-Miguelsanz
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

4.  Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes.

Authors:  Noé Alvarado-Vásquez; Estrella Zapata; Susana Alcázar-Leyva; Felipe Massó; Luis F Montaño
Journal:  Diabetes Metab Res Rev       Date:  2007-10       Impact factor: 4.876

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth.

Authors:  SoJung Lee; Neslihan Gungor; Fida Bacha; Silva Arslanian
Journal:  Diabetes Care       Date:  2007-05-02       Impact factor: 19.112

7.  Ghrelin and cardiovascular diseases.

Authors:  Gaigai Zhang; Xinhua Yin; Yongfen Qi; Lakshmana Pendyala; Jack Chen; Dongming Hou; Chaoshu Tang
Journal:  Curr Cardiol Rev       Date:  2010-02

8.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

Authors:  James B Meigs; Frank B Hu; Nader Rifai; JoAnn E Manson
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

9.  Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes.

Authors:  Bo-wei Liu; Quiang Lu; Chun-ming Ma; Shu-yi Wang; Dong-hui Lou; Xiao-li Lou; Fu-zai Yin
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-07-17       Impact factor: 2.949

10.  Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.

Authors:  Angelo Scuteri; Manfredi Tesauro; Stefano Rizza; Micaela Iantorno; Massimo Federici; Davide Lauro; Umberto Campia; Mario Turriziani; Angelo Fusco; Giulio Cocciolillo; Renato Lauro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-11-01       Impact factor: 4.222

View more
  2 in total

1.  Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism.

Authors:  Kemal Ağbaht; Murat Faik Erdogan; Rifat Emral; Nilgun Baskal; Sevim Güllü
Journal:  Endocrine       Date:  2013-04-10       Impact factor: 3.633

2.  Serum ferritin, an early marker of cardiovascular risk: a study in Chinese men of first-degree relatives with family history of type 2 diabetes.

Authors:  Jun-Ru Liu; Yang Liu; Fu-Zai Yin; Bo-Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2019-04-03       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.